Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adriforant (ZPL-3893787) for Pruritus in Atopic Dermatitis
NCT02424253Phase 2Completed
- Sponsor
- Ziarco Pharma Ltd
- Start
- May 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of adriforant in atopic dermatitis (AD), sponsored by Ziarco Pharma Ltd. Started May 2015; status: completed.
02
Drugs
adriforant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02424253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424253.